• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Niagen Bioscience, Inc. - Common Stock (NQ:NAGE)

    3.860 +0.200 (+5.46%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,398,202
    Open 3.700
    Bid (Size) 3.850 (100)
    Ask (Size) 3.900 (100)
    Prev. Close 3.660
    Today's Range 3.690 - 4.040
    52wk Range 3.565 - 14.69
    Shares Outstanding 68,196,526
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Niagen Bioscience Announces Participation in Upcoming Investor Conferences
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen (NAGE) Q1 2026 Earnings Call Transcript ↗
    Niagen (NAGE) Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    -38.2%
    -38.2%
    1 Month
    -22.2%
    -22.2%
    3 Month
    -23.0%
    -23.0%
    6 Month
    -43.7%
    -43.7%
    1 Year
    -63.6%
    -63.6%

    More News

    Read More
    Niagen Bioscience (NASDAQ:NAGE) Shares Slide After Q1 Earnings Miss and Spending Guidance ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
    From Niagen Bioscience, Inc
    Via Business Wire
    Niagen Bioscience Inc (NASDAQ:NAGE) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
    Via Chartmill
    News headline image
    Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen®
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas
    From Niagen Bioscience, Inc
    Via Business Wire
    Four Stocks at the Intersection of Enzymes, Longevity, and the $400 Billion Wellness Boom (CELV, NAGE, MTEX, CDXS)
    Via AB Newswire
    News headline image
    Niagen Bioscience Increases Share Repurchase Program to $20 Million
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience to Present at the 38th Annual ROTH Conference
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience (NAGE) Earnings Transcript ↗
    Via The Motley Fool
    Topics Intellectual Property
    Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
    Via Chartmill
    News headline image
    Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
    Via FinancialNewsMedia
    News headline image
    Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
    From Niagen Bioscience, Inc
    Via Business Wire
    News headline image
    Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen
    From Niagen Bioscience, Inc.
    Via Business Wire
    News headline image
    Functional Wellness Stocks Explode as $179 Billion Beverage Market Ditches Sugar for Science
    From Equity Insider
    Via GlobeNewswire
    News headline image
    THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
    From USA News Group
    Via GlobeNewswire

    Frequently Asked Questions

    Is Niagen Bioscience, Inc. - Common Stock publicly traded?
    Yes, Niagen Bioscience, Inc. - Common Stock is publicly traded.
    What exchange does Niagen Bioscience, Inc. - Common Stock trade on?
    Niagen Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Niagen Bioscience, Inc. - Common Stock?
    The ticker symbol for Niagen Bioscience, Inc. - Common Stock is NAGE on the Nasdaq Stock Market
    What is the current price of Niagen Bioscience, Inc. - Common Stock?
    The current price of Niagen Bioscience, Inc. - Common Stock is 3.860
    When was Niagen Bioscience, Inc. - Common Stock last traded?
    The last trade of Niagen Bioscience, Inc. - Common Stock was at 05/26/26 04:00 PM ET
    What is the market capitalization of Niagen Bioscience, Inc. - Common Stock?
    The market capitalization of Niagen Bioscience, Inc. - Common Stock is 263.24M
    How many shares of Niagen Bioscience, Inc. - Common Stock are outstanding?
    Niagen Bioscience, Inc. - Common Stock has 263M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.